Generic medicine

Crizotinib: Brands, Price & Uses in Bangladesh

Crizotinib is a tyrosine kinase inhibitor with established, FDA-approved indications in oncology.

Forms:Capsule

About Crizotinib

Indications of Crizotinib

Crizotinib is a tyrosine kinase inhibitor with established, FDA-approved indications in oncology. It is used based on confirmed biomarker status.

  • Metastatic non-small cell lung cancer (NSCLC), ALK-positive: First-line and subsequent treatment of adults with metastatic NSCLC whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an approved test.
  • Metastatic NSCLC, ROS1-positive: Treatment of adults with metastatic NSCLC whose tumors are ROS1-positive.
  • Anaplastic large cell lymphoma (ALCL), ALK-positive: Treatment of relapsed or refractory systemic ALK-positive ALCL in pediatric patients 1 year of age and older and young adults.
  • Inflammatory myofibroblastic tumor (IMT), ALK-positive: Treatment of unresectable, recurrent, or refractory ALK-positive IMT in adults and pediatric patients 1 year of age and older.

Important: ALK or ROS1 biomarker status must be confirmed by a validated test before starting Crizotinib, as efficacy depends entirely on this status. Crizotinib is not indicated in ALK-negative or ROS1-negative tumors.

Dosage & Administration of Crizotinib

Adult NSCLC (ALK-positive or ROS1-positive)

Recommended dose: 250 mg orally twice daily, taken continuously until disease progression or unacceptable toxicity occurs.

Pediatric ALCL and Pediatric IMT (patients ≥1 year and young adults)

Dosing is based on body surface area (BSA): 280 mg/m² orally twice daily (capsules or oral pellets, depending on ability to swallow capsules), with dose selected from a body-surface-area-based dosing table, continued until disease progression or unacceptable toxicity.

Renal FunctionDose Adjustment
Mild to moderate impairment (CrCl ≥30 mL/min)No dose adjustment needed
Severe impairment (CrCl <30 mL/min) not requiring dialysisReduce to 250 mg once daily (adult NSCLC dosing)

Missed dose: If a dose is missed, it should be taken as soon as remembered unless it is less than 6 hours until the next dose, in which case the missed dose should be skipped.

See Administration and Dosage sections below for further details, and Use in Special Populations for hepatic impairment guidance.

Side Effects of Crizotinib

The most common adverse reactions (occurring in ≥25% of patients) associated with Crizotinib in NSCLC trials include:

  • Vision disorders (visual impairment, photopsia, blurred vision, vitreous floaters)
  • Nausea, vomiting, diarrhea, constipation
  • Edema
  • Elevated liver transaminases
  • Fatigue and decreased appetite
  • Upper respiratory tract infection
  • Dizziness and peripheral neuropathy

Serious but less common reactions include hepatotoxicity, interstitial lung disease/pneumonitis, QT prolongation, bradycardia, and severe visual loss - see Precautions and Warnings for detail. In pediatric ALCL/IMT patients, gastrointestinal toxicity (nausea, vomiting, diarrhea) is very common, and myelosuppression (neutropenia, lymphopenia, thrombocytopenia) can occur.

Contraindications of Crizotinib

Crizotinib is contraindicated in patients with known hypersensitivity to Crizotinib or to any component of the formulation.

Frequently Asked Questions about Crizotinib

What is Crizotinib used for?

Crizotinib is used to treat certain types of cancer, most commonly ALK-positive or ROS1-positive metastatic non-small cell lung cancer, and in select cases ALK-positive anaplastic large cell lymphoma or inflammatory myofibroblastic tumor. It is only effective in tumors confirmed to carry these specific genetic changes.

How should I take Crizotinib?

Crizotinib is usually taken as 250 mg by mouth twice daily, with or without food, swallowed whole without crushing or chewing. Always follow your physician's exact dosing instructions, as the dose may differ for children or for patients with liver or kidney problems.

What are the most serious side effects of Crizotinib?

Crizotinib can cause serious liver problems, lung inflammation (interstitial lung disease/pneumonitis), an abnormal heart rhythm (QT prolongation), slow heart rate (bradycardia), and rarely severe vision loss. Report any new breathing difficulty, yellowing of the skin or eyes, irregular heartbeat, fainting, or significant vision changes to your doctor immediately.

Can Crizotinib be used during pregnancy?

Crizotinib can harm an unborn baby and should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus; always consult your physician. Women should use effective contraception during treatment and for at least 45 days after stopping, and men should use effective contraception for at least 90 days after their last dose.

Can I take other medicines with Crizotinib?

Certain medicines, such as strong CYP3A4 inhibitors (like some antifungals or antibiotics) and inducers (like rifampin), can significantly change Crizotinib levels in the blood, while drugs that affect heart rhythm may increase cardiac risk. Always tell your doctor and pharmacist about every medicine, supplement, and grapefruit product you use before starting Crizotinib.

What should I do if I miss a dose or take too much Crizotinib?

If you miss a dose of Crizotinib, take it as soon as you remember unless it is within 6 hours of your next scheduled dose, in which case skip the missed dose. If you or someone else has taken too much Crizotinib, seek immediate medical attention or contact emergency services or a poison control center right away.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles